Ticker Details
Castle Biosciences, Inc.
IPO Date:	July 22, 2019
Sector:	Healthcare
Market Cap:	$1.19B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.98 | 2.95%
Avg Daily Range (30 D):	$0.51 | 1.27%
Avg Daily Range (90 D):	$0.57 | 1.91%

Institutional Daily Volume
Avg Daily Volume:	.25M
Avg Daily Volume (30 D):	.28M
Avg Daily Volume (90 D):	.3M

Trade Size
Avg Trade Size (Sh.):	56
Avg Trade Size (Sh.) (30 D):	43
Avg Trade Size (Sh.) (90 D):	46

Institutional Trades
Total Institutional Trades:	1,412
Avg Institutional Trade:	$1.32M
Avg Institutional Trade (30 D):	$1.93M
Avg Institutional Trade (90 D):	$1.52M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.42M
Avg Closing Trade (30 D):	$2.15M
Avg Closing Trade (90 D):	$1.7M
Avg Closing Volume:	46.17K

News

Dec 12, 2025 @ 12:00 PM Systematic Review and Meta-Analysis Confirms Tissu... Source: Caitlin C. Houghton, M.D.

Nov 17, 2025 @ 12:00 PM Castle Biosciences Earns a Houston Chronicle Top W... Source: Derek Maetzold

Nov 11, 2025 @ 12:00 PM Castle Biosciences to Present at the Piper Sandler... Source: Castle Biosciences Inc.

Oct 26, 2025 @ 7:05 PM New Data at American College of Gastroenterology A... Source: Castle Biosciences, Inc.

Oct 13, 2025 @ 11:00 AM Castle Biosciences to Release Third Quarter 2025 F... Source: Castle Biosciences Inc.

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS		$-.02	$.16
Diluted EPS		$-.02	$.15
Revenue		$83.04M	$86.19M
Gross Profit		$64.34M	$68.56M
Net Income / Loss		$-.5M	$4.52M
Operating Income / Loss		$-6.8M	$-4.25M
Cost of Revenue		$18.7M	$17.63M
Net Cash Flow		$3.32M	$-7.46M
PE Ratio